Drugs for Parkinson's disease

Article Abstract:

The goal of treatment for patients suffering from Parkinson's disease is to slow progression of the disease. Parkinson's disease is characterized by progressive degeneration of nerve cells that contain dopamine. Physicians previously only treated the symptoms of Parkinson's disease with such drugs as levodopa and carbidopa. The effectiveness of these drugs is limited because patients usually develop resistance to them. Patients may also develop side effects after a certain period of time. Selegiline, marketed as Eldepryl, is a new drug that may slow the progression of Parkinson's disease in addition to alleviating the symptoms. Other drugs used to treat Parkinson's disease include dopamine agonists, anticholinergics and amantadine. Some patients with Parkinson's disease may require treatment with antidepressants.

Evaluation, Drug therapy, Dopa, L-dopa, Antiparkinsonian agents, Antiparkinson agents, Eldepryl (Medication), Sinemet (Medication)

---

Pallidotomy for Parkinson's disease

Article Abstract:

Pallidotomy techniques have become more refined for treating dykinesia and other motor abnormalities in Parkinson's disease. During this unilateral brain surgery, the patient stays awake while an electrode is used to produce lesions in the globus pallidus. Surgery has produced excellent results in patients except for visual field defects, paralysis, and speech problems. Parkinsonian symptoms returned in some initially improved patients after the surgical procedure.

Care and treatment, Surgery, Brain, Brain surgery, Tardive dyskinesia, Drug-induced dyskinesia

---

Similar abstracts:

• Abstracts: Pergolide and selegiline for Parkinson's disease. Immunization of college students against meningococcal disease
• Abstracts: Privacy, confidentiality, and security in clinical information systems: dilemmas and opportunities for the nurse executive
• Abstracts: Thyroid gland: US in patients with Hodgkin disease treated with radiation therapy in childhood. Nonneoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression
• Abstracts: Topical metronidazole for rosacea. Topical drugs for aging skin
• Abstracts: Computers in medicine: augmenting medical care in pediatric patients with chronic illnesses. part 2 Advising parents to stop smoking: opportunities and barriers in pediatric practice

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.